pISSN 1226-6051
eISSN 2508-786X

Table. 4.

Table. 4.

Meta-analyses of severity and clinical outcomes

Study N (%)

Severity Outcomes


Mechanical ventilation ICU care Discharge Death Duration of hospitalization (mean, range)a
Lu X, et al.3 3 (1.8) 3 (1.8) 149 (87.1) 1 (0.6) N/R
Su L, et al.11 0 0 9 (100.0) N/R 2-3 week
Zhou Y, et al.12 N/R 0 0 0 N/R
Wei M, et al.13 0 0 N/R N/R N/R
Li W, et al.14 N/R N/R 3 (60.0) N/R 13.0 (12-14)
Zheng F, et al.15 2 (8.0) 2 (8.0) N/R 0 N/R
Cai J, et al.16 N/R N/R 10 (100.0) 0 N/R
Liu H, et al.17 N/R N/R N/R N/R N/R
Liu W, et al.18 N/R 1 (16.7) 6 (100.0) 0 10.0 (5-13)
Qiu H, et al.19 N/R N/R 36 (100.0) 0 14 (10-20)
Wang D, et al.20 0 0 24 (77.4) 0 N/R
Liu M, et al.21 N/R N/R N/R N/R N/R
Meta-analyses outcome (random-effects model)
Patients with positive outcome/included patients (n) 5/245 6/260 237/277 1/288 45/54
Proportion (%) or mean 3.2 4 83 1.9 12.4
95% CI 1.5-6.8 2-7.9 65.4-92.7 0.7-5.1 8.2-16.5
I2 statistics (%) 0 0 64 0 89
τ2 0 0 0.90 0 11.6
P-value 0.51 0.46 <0.01 0.78 <0.01
P-value of Egger’s test 0.7221 0.4724 0.8066 0.0226 0.7027

CI, confidence interval; ICU, intensive care unit, N/R, not reported

a Su L, et al. study was excluded from meta-analysis of hospitalization duration.

Korean J Clin Pharm 2020;30:270-8 https://doi.org/10.24304/kjcp.2020.30.4.270
© 2020 Korean J Clin Pharm